These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25003873)

  • 1. Optimal proteinuria target for renoprotection in patients with IgA nephropathy.
    Nam KH; Kie JH; Lee MJ; Chang TI; Kang EW; Kim DW; Lim BJ; Park JT; Kwon YE; Kim YL; Park KS; An SY; Oh HJ; Yoo TH; Kang SW; Choi KH; Jeong HJ; Han DS; Han SH
    PLoS One; 2014; 9(7):e101935. PubMed ID: 25003873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study.
    Yu MY; Kim YC; Koo HS; Chin HJ
    PLoS One; 2017; 12(11):e0188375. PubMed ID: 29155873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease.
    Barbour SJ; Cattran DC; Kim SJ; Levin A; Wald R; Hladunewich MA; Reich HN
    Kidney Int; 2013 Nov; 84(5):1017-24. PubMed ID: 23739233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    Pediatr Nephrol; 2017 Jul; 32(7):1211-1220. PubMed ID: 28233100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
    Hoshino Y; Moriyama T; Uchida K; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2017 Aug; 21(4):617-623. PubMed ID: 27549901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
    Chen J; Xu H; Peng Z; Lin L; Li C; Zhu X; Liu S
    Clin Exp Nephrol; 2020 Jan; 24(1):73-81. PubMed ID: 31605314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria.
    Komatsu H; Sato Y; Miyamoto T; Tamura M; Nakata T; Tomo T; Nishino T; Miyazaki M; Fujimoto S
    Clin Exp Nephrol; 2016 Feb; 20(1):94-102. PubMed ID: 26123429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
    Mohd R; Mohammad Kazmin NE; Abdul Cader R; Abd Shukor N; Wong YP; Shah SA; Alfian N
    PLoS One; 2021; 16(4):e0249592. PubMed ID: 33831052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.
    Inker LA; Heerspink HJL; Tighiouart H; Chaudhari J; Miao S; Diva U; Mercer A; Appel GB; Donadio JV; Floege J; Li PKT; Maes BD; Locatelli F; Praga M; Schena FP; Levey AS; Greene T
    Am J Kidney Dis; 2021 Sep; 78(3):340-349.e1. PubMed ID: 33775708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    BMC Nephrol; 2017 Mar; 18(1):89. PubMed ID: 28292274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between urinary C4d levels and disease progression in IgA nephropathy.
    Dong Y; Wang Z; Guo W; Zhu L; Zhou X; Shi S; Liu L; Lv J; Zhang H
    Nephrol Dial Transplant; 2024 Jul; 39(8):1279-1287. PubMed ID: 38178632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S; Yang X; Luo J; Guo H
    Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria.
    Nagasawa Y; Yamamoto R; Shinzawa M; Shoji T; Hasuike Y; Nagatoya K; Yamauchi A; Hayashi T; Kuragano T; Moriyama T; Isaka Y
    Clin Exp Nephrol; 2020 Oct; 24(10):927-934. PubMed ID: 32642919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X; Liu Y; Lv J; Shi S; Liu L; Chen Y; Zhang H
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy.
    Canney M; Barbour SJ; Zheng Y; Coppo R; Zhang H; Liu ZH; Matsuzaki K; Suzuki Y; Katafuchi R; Reich HN; Cattran D; ;
    J Am Soc Nephrol; 2021 Feb; 32(2):436-447. PubMed ID: 33514642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of proteinuria improves prognosis in IgA nephropathy.
    Reich HN; Troyanov S; Scholey JW; Cattran DC;
    J Am Soc Nephrol; 2007 Dec; 18(12):3177-83. PubMed ID: 17978307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Immunosuppressive Treatment May Improve Short-Term Renal Outcomes in Chinese Patients with Advanced IgA Nephropathy.
    Tan L; Tang Y; Peng W; Mathew BS; Qin W
    Kidney Blood Press Res; 2018; 43(4):1333-1343. PubMed ID: 30099439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.